Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: In the EU, approximately 165 million people suffer from mental health disorders, namely anxiety, mood disorders, and substance abuse. These mental health disorders have resulted in both direct and indirect global economic costs estimated at US $2.5 trillion in 2010, with the indirect costs (USD $ 1.7 trillion) being significantly higher than the direct costs (USD $ 0.8 trillion), contrasting the trends of other key diseases, such as cardiovascular disease and cancer [1]. Concurrently, problematic alcohol consumption is considered the causal factor of more than 200 diseases, leading to 5.1% of all global diseases and damages being attributed to alcohol abuse. In addition to the risks posed to health, the social and economic damages involved not only for individuals suffering from alcohol abuse, but for society in general, must be taken into consideration [2]. Monitoring mental health outcomes has traditionally been based on heuristic decisions often based on scarce, subjective evidence, making the clinical decisions made by professionals, as well as the monitoring of these diseases, subject to flaws [3]. However, the "digital phenotype", which refers to the analysis of data collected by measuring human behavior with mobile sensors and smart bracelets, is a promising tool for filling this gap in current clinical practice, offering objective evidence in an otherwise subjective field of diagnosis, namely through the utilization of digital biomarkers [4]. Biomarkers are physiological, pathologic, or anatomic characteristics measured objectively and used to evaluate a patient’s health in the status quo by comparing their current biomarkers to ideal, healthy biomarkers. In the wake of advancing technology, “digital biomarkers” are emerging as a new form of tracking patient’s health. Digital biomarkers are considered digital as they utilize sensors and computational tools to collect data. These measurements can be taken outside of a traditional clinical environment using sensors such as mobile device sensors and wearable sensors [5]. Numerous studies have shown that information collected from behavioral and physiological sensors can be used to improve conventional evaluations of patients with symptoms of anxiety. In addition, patients who use these platforms show higher levels of consistency with their treatment plans than those only involved in conventional practice [6]. There are various examples of the effectiveness of digital phenotype data-collection in analyzing anxiety disorders: There exist significant patterns between the time spent in certain places and depression and anxiety, although these relationships were not consistent [7]. It has been shown that sensors integrated into smart bracelets measuring conductance and skin temperature can be utilized to reach a 78.3% (148/189) accuracy in classifying students into groups of high or low stress levels. Furthermore, the sensors provided a 79% (37/47) accuracy rate for classifying students’ state of mental health [8]. Furthermore, analysis from sensors tracking GPS location and incoming and outgoing text messages and calls collected from 54 college students over a two week period indicated that levels of social anxiety can be predicted with an accuracy of up to 85% by tracking these variables [9]. Alongside digital tracking of anxiety symptoms, there also exist various applications designed to facilitate the monitoring of alcohol consumption in patients with alcohol abuse disorder [10,11,12]. Although more research is needed, these applications have been shown to be effective in increasing patients’ ability to manage their condition [10], leading to reductions in days of consumption risk [11]. In addition, these tools allow for patients’ usual professional caretaker to monitor their condition, allowing for more informed care [10]. Therefore with REMOTE study we aim to provide valuable insights and knowledge about digital biomarkers in alcohol use disorders and anxiety disorders. Objective: Because of the emerging research on digital biomarkers and in the accuracy of passive monitoring of data in patients with mental health disorders, we pose a study in a group of 60 participants split into two subgroups of 30 participants. The primary objective of this study is to analyze the digital physiological patterns of two groups of participants, one group with symptoms of anxiety disorder and alcohol abuse disorder and one healthy control group without anxiety and alcohol abuse disorder, using data collected from a mobile (smartphone) and wearable (FitBit) sensor. The data collected from the sensors trough humanITcare platform will then be compared with the symptoms validated in clinical questionnaires, which participants will take four times over the course of the study, in order to determine whether sensor data is an efficient and accurate means of presenting objective diagnoses rather than the subjective diagnosis of the status quo. The secondary objective of this study is to analyze usability and patient satisfaction with the data collection service provided by the application. Methods: DESING: This study is a case-controlled, prospective study consisting of two groups: one group of healthy control...